Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Clinical trial NCT04698915 · TERMINATED
Trial details
- NCT number
- NCT04698915
- Sponsor
- Galera Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2023-11-30
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.